Delta4ai

Merry Christmas from Delta4! 🎄✨ As we celebrate the joy and hope of this festive season, we’re reminded of the importance of health and well-being for all. From our team to yours, may your holidays be filled with peace, happiness, and good health. #Delta4 #HappyHolidays #HolidaySpirit

🎙️ AI Drug Development - Delta4's Roots From the early days in bioinformatics in the 2000s to today’s breakthroughs with AI and large language models, the journey has been clear: ✅ Grow from academic roots ✅ Professionalize approaches ✅ Bring precision-driven innovation to patients While AI excels at handling massive datasets, humans still lead in understanding context—for now. Tune in as we explore how machine learning is reshaping drug discovery and where human expertise meets algorithmic power in biomedical research. 🔗 Listen here: https://lnkd.in/dSR4SKJ6 #AI #Bioinformatics #DrugDiscovery #MachineLearning #HealthcareInnovation #AIInDrugDiscovery #Delta4 #LifeSciences #PharmaTech #HyperC #Podcast

🎙️At Delta4, we’re transforming drug discovery. In our latest podcast, we discuss how Hyper-C, our AI-powered platform, identifies untapped potential by mapping drug-disease connections and providing actionable, transparent insights—eliminating the “black box” problem. Hear how we’re helping pharma companies save time, cut costs, and bring life-changing treatments to patients faster. 💊 🎧 Listen now: https://lnkd.in/eTBqWmKc #Delta4Podcast #AIInHealthcare #DrugDiscovery #HyperC #LifeSciences #Therapeutics

🎉 The Delta4 team had an incredible night celebrating our yearly company Christmas dinner at the elegant TERRAE restaurant in Vienna's first district. 🥂🍽️ Here’s to another year of innovation, collaboration, and success in AI-powered drug discovery and indication expansion. Cheers to making the future healthier together! 🌟💊 #Delta4 #AIInnovation #DrugDiscovery #ChristmasDinner #FestiveSeason #TeamCelebration #Vienna #AIInHealthcare #LifeSciences #CompanyCulture

🌟 PerMediK Virtual Mobility Spotlight 🌟 We’re excited to highlight the exceptional work of Matthias Ley, whose Virtual Mobility Grant within the PerMediK Network focused on advancing Chronic Kidney Disease (CKD) research through innovative programming tools. Matthias conceptualized and developed a Python programming workshop tailored specifically for CKD research, equipping researchers with the skills and tools needed to analyze complex datasets and model disease mechanisms. His work aligns perfectly with PerMediK's mission of fostering collaboration and driving innovation in personalized medicine. Congrats to Matthias for this outstanding contribution to the network! #PerMediK #VirtualMobility #CKD #DataScience #PythonProgramming #PersonalizedMedicine #Collaboration Let us know if you'd like to learn more about Virtual Mobility Grants or share your own success story! 🚀 Delta4ai

🌟 Virtual Mobility Spotlight! 🌟 We’re proud to highlight the work of Kinga Keska-Izworska, PhD, Computational Biologist at Delta4, who recently completed a Virtual Mobility Grant within the PerMediK Network. Her efforts significantly advanced kidney disease research and drug modeling, perfectly aligning with PerMediK’s mission to drive innovation in personalized medicine. This collaboration showcases the power of connection and teamwork in achieving impactful scientific progress. 💡 #PerMediK #VirtualMobility #PersonalizedMedicine #CKD #Collaboration #ResearchSuccess

Calling out PhD researchers in our #REPO4EU network! 🧑🔬 🟣 Do you want to help crafting innovative #DrugRepurposing strategies for #ProstateCancer? 🟣 Are you passionate about applying your knowledge and skills in #Bioinformatics to drive #HealthcareInnovation? 🟣 Would you be interested in growing professionally while working with a #TechBio company at the forefront of digital drug discovery and development? Our partners from Delta4ai are currently offering a fully funded 3-year PhD position in Vienna! This is a very exciting opportunity to join a wider team of 13 research centres involved in PROMOTE, a European Doctoral Network program focused on the multidisciplinary education of doctoral candidates in -omics and AI mediated intervention to improve the clinical management of Prostate Cancer. Learn more about the role and how to apply 👇 https://lnkd.in/eugP8UER

Spotlight on selected 2024 FDA Approvals: Advancing Healthcare 🌟 This year, groundbreaking FDA drug approvals are paving the way for a healthier, brighter future. Here's a focused look at key areas where they are making a meaningful impact on patient care and treatment outcomes: 💓 Heart Hypertension is a condition marked by persistently high blood pressure, increasing the risk of heart attacks and strokes. 💊Tryvio: A game-changer that helps lower blood pressure and reduce cardiovascular events. 🩸 Kidney Anemia due to chronic kidney disease (CKD) is a common complication that affects many CKD patients. 💊Vafseo: A treatment designed to manage anemia and improve outcomes for CKD patients. ⚕️ Liver Primary biliary cholangitis (PBC), a chronic liver disease that can lead to severe liver damage if untreated. 💊Iqirvo & Livdelzi: These drugs, in combination with ursodeoxycholic acid (UDCA), provide an effective treatment option for PBC. 🌬️ Lung Pulmonary arterial hypertension (PAH): a rare, progressive disease that affects blood vessels in the lungs. 💊Winrevair: Offers improved quality of life for patients with PAH. Chronic obstructive pulmonary disease (COPD): a progressive condition that makes breathing difficult. 💊Ohtuvayre: Provides relief and better management of COPD symptoms. Each approval is a significant step toward improving patient outcomes and tackling serious health challenges. 💙 #FDAApprovals2024 #InnovationInHealthcare #Delta4 #newtreatments #PBC #CKD #COPD

Passion and innovation at the forefront of rare disease drug discovery. Our dedicated team is transforming challenges into breakthroughs. Join us on this journey and be part of the change! https://lnkd.in/dVQwAzhi #Delta4 #InnovativeTreatments #HealthTechPioneers

🚨 Exciting Opportunity Alert! 🚨 Delta4 is offering a fully funded 3-year PhD position in Vienna, focused on computational drug screening and synthetic lethality drug repurposing for prostate cancer. As part of the prestigious PROMOTE (Prostate cancer omics mediated intervention) consortium, this role aims to harness AI and multi-omics approaches to develop innovative, non-invasive treatments and identify new drugs and drug combinations for (advanced) prostate cancer. You’ll collaborate with top-tier researchers, gain hands-on experience in cutting-edge techniques, and train in partner labs across Europe. If you have a background in bioinformatics, a passion for AI-driven healthcare innovation, and a master’s degree in a related field, this could be your next career milestone! 🌱 Apply now and make a real impact on cancer care. Learn more: https://lnkd.in/dkbTMUZd #biotechjobs #jobs #careerinscience #bioinformatics #AI #prostatecancer #cancerresearch #delta4